Project Survival
Pancreatic Cancer Biomarker Discovery Study

This sample-collection study is open to participants in several categories: healthy volunteers (with or without a family history of pancreatic cancer), and individuals diagnosed with pancreatitis or any stage of pancreatic cancer. All participants will submit urine and blood samples; pancreatitis and pancreatic cancer patients will also submit tissue samples if biopsy or surgery is part of the care being provided by their doctor. In partnership with Berg Health, LLC, biomarkers will be investigated for potential use in early detection of pancreatic cancer, to determine prognosis of patients, and to find the most appropriate treatments for patients. Learn more.

Find a Clinical Trial Near You

PCRT has the resources and ability to locate research that is close to you. Click on the area below that most closely matches your current location for a list of the closest locations to find pancreatic cancer clinical trials.

List of Clinical Trials

A 3-Arm Phase 2 Double-Blind Randomized Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT02289898

A Phase 2 Study of BPM31510 (Ubidecarenone, USP) Nanosuspension Injection Administered Intravenously with or without Gemcitabine as 2nd /3rd line therapy in Advanced Pancreatic Cancer Patients
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT02650804

Project Survival-Prospective Biomarker Discovery to Transform Diagnosis and Treatment for Patients With Pancreatic Diseases and Cancer
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT02781012

A Phase IB/2 Pilot Trial of Nab-Paclitaxel plus Cisplatin plus Gemcitabine (NAPLAGEM) in patients with previously untreated metastatic pancreatic ductal Adenocarcinoma.
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01893801

Nab-Paclitaxel plus Gemcitabine (Induction therapy), and FOLFIRINOX (Consolidation therapy), and Molecular Profiling (Maintenance Therapy) for Patients With Advanced Pancreatic Cancer: CLOSED TO ENROLLMENT.
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01488552

PEGPH20 plus Nab-Paclitaxel plus Gemcitabine compared with Nab-Paclitaxel Plus Gemcitabine in Patients with Stage IV Untreated Pancreatic Cancer.
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01839487

A Phase IB/2 study of M402 (heparin sulfate mimetic) with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic pancreatic Cancer. CLOSED TO ENROLLMENT
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01621243

An International Multi-Center, Double-Blind, randomized, Phase III Tiral of 90Y-Clivatuzumab Tetraxetan plus Low-Dose Gemcitabine Versus Placebo plus Low-Dose Gemcitabine in patients with Metastatic (Stage IV) Pancreatic Adenocarcinoma who have received at least two prior treatments (PANCRIT-1).
CLOSED TO ENROLLMENT
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01956812

A Phase IB/2 study of OMP-59R5 in Combination with Nab-Paclitaxel and Gemcitabine in Subjects with Previously untreated Stage IV Pancreatic Cancer.
CLOSED TO ENROLLMENT
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01647828

Pilot Study of Nab-paclitaxel +gemcitabine to Treat Potentially Operable pancreatic cancer Patients.
CLOSED TO ENROLLMENT
Clinical Trials.gov link - click here
ClinicalTrials.gov Identifier:
NCT01298011